This post contains spoilers for the series finale of Stranger Things. The Stranger Things kids are all right. They’re a little banged up and eternally trauma bonded, haunted by violent images of the ...

Something has seemed wrong since, let’s say, some time in 2016. Whatever your political, economic, or religious affiliations, there’s no denying our world has veered down a polarized path in the last ...

Netflix’s latest Korean blockbuster The Great Flood has surged to the top of the platform’s global charts for nonglobal films, but audiences are divided over its cryptic ending and philosophical twist ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Netflix's new show The Abandons has a true cliffhanger ending, and we're here to break it down. One of the love stories of the season does get a (kind of) resolution. Did [SPOILER] and [SPOILER] ...

Monday - Friday, 6:00 - 7:00 PM ET It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

IT: Welcome to Derry Episode 5 ends with a development that should send chills down any hardcore Stephen King fan’s spine. It’s not enough that our heroes finally visited the house on Neibolt Street ...

This is this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, leaders and investors straight to your inbox. Click here to get on the ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...